Advertisement
Screener

DYADIC INTERNATIONAL INC (DYAI) Graph

DYAI Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $961.14K; Cost of revenue $984.16K; Research and development $332.62K; Income tax (m).
  • 2026-03-31: Revenue $1.11M; Cost of revenue $791.84K; Research and development $476.07K; Income tax $0.00.
  • 2025-12-31: Revenue $565.53K*; Cost of revenue $384.61K*; Research and development $458.44K*; Income tax (m).
  • 2025-09-30: Revenue $1.16M; Cost of revenue $1.02M; Research and development $571.87K; Income tax (m).

Counterparty Name

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

DYAI revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Cepi$584.07KGates Foundation$253.19KProliant Agreement$0.00Revenue$961.14KCost of revenue$984.16KOperating income-$2.05MResearch & development$332.62KNet income-$2.12M

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

DYAI revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Research AndDevelopment Expenses$123.89KGrant$837.25KRevenue$961.14KCost of revenue$984.16KOperating income-$2.05MResearch & development$332.62KNet income-$2.12M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30$961.14K$984.16K$332.62K(m)-$2.12M
2026-03-31$1.11M$791.84K$476.07K$0.00-$1.95M
2025-12-31$565.53K*$384.61K*$458.44K*(m)(m)
2025-09-30$1.16M$1.02M$571.87K(m)-$1.98M
2025-06-30$966.63K$613.59K$629.38K(m)-$1.79M
2025-03-31$393.57K$297.66K$494.98K(m)-$2.03M
2024-09-30$1.96M$395.89K$460.24K(m)-$203.46K
2024-06-30$385.90K$301.96K$515.63K(m)-$2.05M
2024-03-31$334.62K$143.96K$522.72K(m)-$2.01M
2023-09-30$397.06K$105.87K$716.35K(m)-$1.61M
2023-06-30$837.16K$792.94K$917.55K(m)-$2.15M
2023-03-31$978.05K$726.92K$810.57K(m)-$956.44K
2022-09-30$879.60K$602.85K$743.59K(m)-$1.81M
2022-06-30$658.55K$411.11K$1.83M(m)-$3.29M
2022-03-31$648.43K$404.75K$1.34M(m)-$2.49M
2021-09-30$692.93K$392.54K$1.90M(m)-$1.72M
2021-06-30$937.09K$829.50K$2.21M(m)-$3.85M
2021-03-31$460.52M$390.76M$1.81B(m)-$3.29M
2020-09-30$416.36K$266.93K$986.05K$0.00-$2.50M
2020-06-30$524.27K$624.24K$1.12M$0.00-$2.65M
2020-03-31$315.37K$278.18K$755.45K$0.00-$2.21M
2019-09-30$454.51K$384.80K$841.34K$0.00-$1.70M
2019-06-30$390.87K$322.23K$818.24K$0.00-$2.70M
2019-03-31$402.53K$327.90K$692.37K$900.00-$2.18M
2018-09-30$262.96K$243.41K$476.63K$0.00-$1.54M
2018-06-30$161.29K$129.12K$601.20K$0.00-$1.60M
2018-03-31$184.33K$146.81K$576.88K$0.00-$2.04M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30$2.07M$1.78M$808.69K$0.00-$4.08M
2025-06-30$1.36M$911.25K$1.12M(m)-$3.82M
2024-06-30$720.51K$445.91K$1.04M(m)-$4.05M
2023-06-30$1.82M$1.52M$1.73M(m)-$3.11M
2022-06-30$1.31M$815.86K$3.17M(m)-$5.78M
2021-06-30$1.40M$1.22M$4.02M(m)-$7.14M
2020-06-30$839.64K$902.42K$1.87M$0.00-$4.87M
2019-06-30$793.40K$650.13K$1.51M$900.00-$4.87M
2018-06-30$345.62K$275.93K$1.18M$0.00-$3.64M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-09-30$2.52M$1.94M$1.70M(m)-$5.80M
2024-09-30$2.68M$841.80K$1.50M(m)-$4.26M
2023-09-30$2.21M$1.63M$2.44M(m)-$4.72M
2022-09-30$2.19M$1.42M$3.92M(m)-$7.59M
2021-09-30$2.09M$1.61M$5.92M(m)-$8.86M
2020-09-30$1.26M$1.17M$2.86M$0.00-$7.37M
2019-09-30$1.25M$1.03M$2.35M$900.00-$6.57M
2018-09-30$608.58K$519.33K$1.65M$0.00-$5.18M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-12-31$3.09M$2.32M$2.15M(m)-$7.36M
2024-12-31$3.50M$1.19M$2.04M(m)-$5.81M
2023-12-31$2.90M$1.98M$3.30M(m)-$6.80M
2022-12-31$2.93M$2.12M$4.50M(m)-$9.74M
2021-12-31$2.40M$1.94M$8.39M$0.00-$13.07M
2020-12-31$1.60M$1.42M$3.87M$31.32K-$9.33M
2019-12-31$1.68M$1.46M$3.09M$10.31K-$8.31M
2018-12-31$1.30M$1.03M$2.10M-$1.01M-$5.69M
2017-12-31$758.42K$680.20K$1.77M-$66.69K-$2.14M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioCardia, Inc. (BCDA)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
IN8BIO, INC. (INAB)United States$0.012B-0.76
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23